|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 11-18 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 24-05-06 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 456K 420K 393K 737K 48.97M 750K 5.04M 1.95M 24.14M 1.95M 1.91M 83.89M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19.37M 17.84M 16.68M 31.29M 2.08B 31.87M 214M 82.93M 1.03B 82.8M 80.98M 3.56B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.61% | +3.75% | +43.86% | +151.74% | 996B | |
| +1.70% | +7.75% | +61.60% | +50.39% | 580B | |
| +3.17% | +12.06% | +30.86% | +79.77% | 415B | |
| +5.66% | -2.44% | +22.01% | +15.66% | 326B | |
| +1.34% | +6.74% | +32.63% | +41.70% | 280B | |
| +1.09% | +6.90% | +37.22% | +24.53% | 284B | |
| +1.32% | +12.69% | -27.48% | -41.27% | 210B | |
| +1.47% | +5.41% | +26.93% | +58.35% | 190B | |
| -0.18% | +0.90% | +17.88% | +63.10% | 155B | |
| Average | +1.91% | +2.68% | +27.28% | +49.33% | 381.86B | |
| Weighted average by Cap. | +2.05% | +2.18% | +35.28% | +72.60% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.43M 1.32M 1.23M 2.31M 154M 2.35M 15.8M 6.12M 75.68M 6.11M 5.98M 263M | 2.38M 2.09M 1.93M 1.8M 3.38M 225M 3.45M 23.16M 8.97M 111M 8.96M 8.76M 386M |
| Net income | -9.14M -8.03M -7.4M -6.92M -12.98M -863M -13.21M -88.78M -34.39M -425M -34.33M -33.58M -1.48B | -8.02M -7.04M -6.49M -6.07M -11.38M -756M -11.58M -77.83M -30.15M -373M -30.1M -29.44M -1.3B |
| Net Debt | 17.85M 15.68M 14.45M 13.51M 25.34M 1.68B 25.8M 173M 67.15M 830M 67.05M 65.58M 2.89B | 21.53M 18.91M 17.42M 16.29M 30.56M 2.03B 31.12M 209M 80.97M 1B 80.85M 79.08M 3.48B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
